Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelius Cilliers

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
"Standing by" for Bystander Effects: Dual-Isotope Imaging of Antibody-Drug Conjugate and Payload DistributionCornelius Cilliers, Greg M Thurber
Pharmaceutics|February 9, 2020
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio ImagingIan Nessler, Cornelius Cilliers, Greg M Thurber
Molecular Pharmaceutics|March 16, 2017
Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma ClearanceCornelius Cilliers, Ian Nessler, Nikolas Christodolu, et al.
Molecular Imaging and Biology|April 15, 2015
Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging AgentsCornelius Cilliers, Jianshan Liao, Lydia Atangcho, et al.
The AAPS Journal|June 12, 2016
Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for EfficacyCornelius Cilliers, Hans Guo, Jianshan Liao, et al.
Cancer Research|December 9, 2017
Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host SurvivalCornelius Cilliers, Bruna Menezes, Ian Nessler, et al.
Journal of Pharmaceutical Sciences|July 23, 2014
Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumorsSumit Bhatnagar, Emily Deschenes, Jianshan Liao, et al.
Clinical Pharmacology and Therapeutics|November 26, 2024
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug InteractionsCornelius Cilliers, Eleanor Howgate, Hannah M Jones, et al.
The AAPS Journal|January 17, 2020
An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing RegimensBruna Menezes, Cornelius Cilliers, Timothy Wessler, et al.
Cancer Chemotherapy and Pharmacology|December 19, 2024
Absorption, single-dose and steady-state metabolism, excretion, and pharmacokinetics of adagrasib, a KRAS<sup>G12C</sup> inhibitorLisa Rahbaek, Cornelius Cilliers, Christopher J Wegerski, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
"Standing by" for Bystander Effects: Dual-Isotope Imaging of Antibody-Drug Conjugate and Payload DistributionCornelius Cilliers, Greg M Thurber
Pharmaceutics|February 9, 2020
Practical Guide for Quantification of In Vivo Degradation Rates for Therapeutic Proteins with Single-Cell Resolution Using Fluorescence Ratio ImagingIan Nessler, Cornelius Cilliers, Greg M Thurber
Molecular Pharmaceutics|March 16, 2017
Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma ClearanceCornelius Cilliers, Ian Nessler, Nikolas Christodolu, et al.
Molecular Imaging and Biology|April 15, 2015
Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging AgentsCornelius Cilliers, Jianshan Liao, Lydia Atangcho, et al.
The AAPS Journal|June 12, 2016
Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for EfficacyCornelius Cilliers, Hans Guo, Jianshan Liao, et al.
Cancer Research|December 9, 2017
Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host SurvivalCornelius Cilliers, Bruna Menezes, Ian Nessler, et al.
Journal of Pharmaceutical Sciences|July 23, 2014
Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumorsSumit Bhatnagar, Emily Deschenes, Jianshan Liao, et al.
Clinical Pharmacology and Therapeutics|November 26, 2024
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug InteractionsCornelius Cilliers, Eleanor Howgate, Hannah M Jones, et al.
The AAPS Journal|January 17, 2020
An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing RegimensBruna Menezes, Cornelius Cilliers, Timothy Wessler, et al.
Cancer Chemotherapy and Pharmacology|December 19, 2024
Absorption, single-dose and steady-state metabolism, excretion, and pharmacokinetics of adagrasib, a KRAS<sup>G12C</sup> inhibitorLisa Rahbaek, Cornelius Cilliers, Christopher J Wegerski, et al.
Pageof 2